BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24562822)

  • 1. Performance profile of a FDG-PET cancer screening program for detecting gastric cancer: results from a nationwide Japanese survey.
    Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Inoue T
    Jpn J Radiol; 2014 May; 32(5):253-9. PubMed ID: 24562822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of breast cancer in an FDG-PET cancer screening program: results of a nationwide Japanese survey.
    Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Inoue T
    Clin Breast Cancer; 2015 Apr; 15(2):e139-46. PubMed ID: 25454690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of thyroid cancer by an FDG-PET cancer screening program: a Japanese nation-wide survey.
    Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Inoue T
    Anticancer Res; 2014 Aug; 34(8):4439-45. PubMed ID: 25075083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance profile of FDG-PET and PET/CT for cancer screening on the basis of a Japanese Nationwide Survey.
    Minamimoto R; Senda M; Uno K; Jinnouchi S; Iinuma T; Ito K; Okuyama C; Oguchi K; Kawamoto M; Suzuki Y; Tsukamoto E; Terauchi T; Nakashima R; Nishio M; Nishizawa S; Fukuda H; Yoshida T; Inoue T
    Ann Nucl Med; 2007 Nov; 21(9):481-98. PubMed ID: 18030580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current status of an FDG-PET cancer screening program in Japan, based on a 4-year (2006-2009) nationwide survey.
    Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Murano T; Fukuda H; Iinuma T; Uno K; Nishizawa S; Tsukamoto E; Iwata H; Inoue T; Oguchi K; Nakashima R; Inoue T
    Ann Nucl Med; 2013 Jan; 27(1):46-57. PubMed ID: 23086544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of colorectal cancer and adenomas by FDG-PET cancer screening program: results based on a nationwide Japanese survey.
    Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Inoue T
    Ann Nucl Med; 2014 Apr; 28(3):212-9. PubMed ID: 24347363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of various malignant neoplasms detected by FDG-PET cancer screening program: based on a Japanese Nationwide Survey.
    Minamimoto R; Senda M; Terauchi T; Jinnouchi S; Inoue T; Iinuma T; Inoue T; Ito K; Iwata H; Uno K; Oku S; Oguchi K; Tsukamoto E; Nakashima R; Nishizawa S; Fukuda H; Murano T; Yoshida T
    Ann Nucl Med; 2011 Jan; 25(1):45-54. PubMed ID: 20953985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of lung cancer by FDG-PET cancer screening program: a nationwide Japanese survey.
    Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Uno K; Iinuma T; Murano T; Nakashima R; Inoue T
    Anticancer Res; 2014 Jan; 34(1):183-9. PubMed ID: 24403460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
    Lee DY; Lee CH; Seo MJ; Lee SH; Ryu JS; Lee JJ
    Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of 18F-2-deoxy-2-fluoro-glucose positron emission tomography for gastric cancer screening in asymptomatic individuals undergoing endoscopy.
    Shoda H; Kakugawa Y; Saito D; Kozu T; Terauchi T; Daisaki H; Hamashima C; Muramatsu Y; Moriyama N; Saito H
    Br J Cancer; 2007 Dec; 97(11):1493-8. PubMed ID: 18040274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography and Laparoscopy for Staging of Locally Advanced Gastric Cancer: A Multicenter Prospective Dutch Cohort Study (PLASTIC).
    Gertsen EC; Brenkman HJF; van Hillegersberg R; van Sandick JW; van Berge Henegouwen MI; Gisbertz SS; Luyer MDP; Nieuwenhuijzen GAP; van Lanschot JJB; Lagarde SM; Wijnhoven BPL; de Steur WO; Hartgrink HH; Stoot JHMB; Hulsewe KWE; Spillenaar Bilgen EJ; van Det MJ; Kouwenhoven EA; van der Peet DL; Daams F; van Grieken NCT; Heisterkamp J; van Etten B; van den Berg JW; Pierie JP; Eker HH; Thijssen AY; Belt EJT; van Duijvendijk P; Wassenaar E; van Laarhoven HWM; Wevers KP; Hol L; Wessels FJ; Haj Mohammad N; van der Meulen MP; Frederix GWJ; Vegt E; Siersema PD; Ruurda JP;
    JAMA Surg; 2021 Dec; 156(12):e215340. PubMed ID: 34705049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of FDG PET/CT for surveillance in asymptomatic gastric cancer patients after curative surgical resection.
    Lee JW; Lee SM; Son MW; Lee MS
    Eur J Nucl Med Mol Imaging; 2016 May; 43(5):881-888. PubMed ID: 26611426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Added value of pretreatment (18)F-FDG PET/CT for staging of advanced gastric cancer: Comparison with contrast-enhanced MDCT.
    Kawanaka Y; Kitajima K; Fukushima K; Mouri M; Doi H; Oshima T; Niwa H; Kaibe N; Sasako M; Tomita T; Miwa H; Hirota S
    Eur J Radiol; 2016 May; 85(5):989-95. PubMed ID: 27130061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.
    Smyth E; Schöder H; Strong VE; Capanu M; Kelsen DP; Coit DG; Shah MA
    Cancer; 2012 Nov; 118(22):5481-8. PubMed ID: 22549558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Usefulness of ¹⁸F-fluoro-2-deoxyglucose positron emission tomography in evaluation of gastric cancer stage].
    Yoon NR; Park JM; Jung HS; Cho YK; Lee IS; Choi MG; Chung IS; Song KY; Park CH
    Korean J Gastroenterol; 2012 May; 59(5):347-53. PubMed ID: 22617528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving patient selection for 18F-FDG PET scanning in the staging of gastric cancer.
    Kaneko Y; Murray WK; Link E; Hicks RJ; Duong C
    J Nucl Med; 2015 Apr; 56(4):523-9. PubMed ID: 25745094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography.
    Ohata H; Oka M; Yanaoka K; Shimizu Y; Mukoubayashi C; Mugitani K; Iwane M; Nakamura H; Tamai H; Arii K; Nakata H; Yoshimura N; Takeshita T; Miki K; Mohara O; Ichinose M
    Cancer Sci; 2005 Oct; 96(10):713-20. PubMed ID: 16232204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting recurrence of gastric cancer: the value of FDG PET/CT.
    Park MJ; Lee WJ; Lim HK; Park KW; Choi JY; Kim BT
    Abdom Imaging; 2009 Jul; 34(4):441-7. PubMed ID: 18543017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical usefulness of F-18 FDG PET in lymphoepithelioma-like gastric carcinoma.
    Park S; Lee D; Lee KM; Han SU; Lee JH; Lee SJ; An YS; Yoon JK
    Eur J Radiol; 2017 Sep; 94():160-166. PubMed ID: 28712702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET/CT role in staging of gastric carcinomas: comparison with conventional contrast enhancement computed tomography.
    Altini C; Niccoli Asabella A; Di Palo A; Fanelli M; Ferrari C; Moschetta M; Rubini G
    Medicine (Baltimore); 2015 May; 94(20):e864. PubMed ID: 25997066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.